IGF2BP3 and renal cell adenocarcinoma: IGF2BP3 which bind Lnc-DMDRMR to stabilize the cell-cycle kinase CDK4 in an m6A-dependent manner, ultimately enhancing the G1-S transition and promoting tumour progression in RCC.